Abstract: 582 ATTAINMENT OF SINGLE/DUAL TREATMENT LEVELS FOR LDL-C AND NON-HDL-C, APOB, OR HS-CRP IN PATIENTS WITH METABOLIC SYNDROME (MS): EZETIMIBE(E)/SIMVASTATIN(S) VS ATORVASTATIN(A)
Ballantyne, C, Grundy, S, Hsueh, W, Parving, H, Robinson, J, Rosen, J, Lin, J, Lowe, R, Shah, A, Tomassini, J, Tershakovec, AVolume:
10
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/s1567-5688(09)70339-3
Date:
June, 2009
File:
PDF, 233 KB
english, 2009
File converter
More search results
More benefits 
